2020
DOI: 10.1080/14756366.2020.1758692
|View full text |Cite
|
Sign up to set email alerts
|

Recent progress in the development of steroid sulphatase inhibitors – examples of the novel and most promising compounds from the last decade

Abstract: The purpose of this review article is to provide an overview of recent achievements in the synthesis of novel steroid sulphatase (STS) inhibitors. STS is a crucial enzyme in the biosynthesis of active hormones (including oestrogens and androgens) and, therefore, represents an extremely attractive molecular target for the development of hormone-dependent cancer therapies. The inhibition of STS may effectively reduce the availability of active hormones for cancer cells, causing a positive therapeutic effect. Her… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 107 publications
0
11
0
Order By: Relevance
“…The ineffectiveness of the tested arylsulfamates towards BT4656 S1_11 is likely due to this family of sulfatases having evolved to target polar carbohydrate substrates, rendering the enzyme incompatible with the binding of aryl moieties, the hydrophobic substrates of the aryl sulfatases. Significant advances have been made in the design of inhibitors targeting steroid sulfatases involved in hormone-dependent cancers and some are in Phase II clinical trials [ 39 ]. There are, however, currently no targeted, effective inhibitors of carbohydrate sulfatases despite their emergence as novel targets for disease intervention [ 26 , 40 , 41 ].…”
Section: Resultsmentioning
confidence: 99%
“…The ineffectiveness of the tested arylsulfamates towards BT4656 S1_11 is likely due to this family of sulfatases having evolved to target polar carbohydrate substrates, rendering the enzyme incompatible with the binding of aryl moieties, the hydrophobic substrates of the aryl sulfatases. Significant advances have been made in the design of inhibitors targeting steroid sulfatases involved in hormone-dependent cancers and some are in Phase II clinical trials [ 39 ]. There are, however, currently no targeted, effective inhibitors of carbohydrate sulfatases despite their emergence as novel targets for disease intervention [ 26 , 40 , 41 ].…”
Section: Resultsmentioning
confidence: 99%
“…This review will explore the past, present, and future of STS inhibitor development and will in particular focus on the research by Prof. Barry Potter, who has been instrumental in the many successes in this field. Other recent reviews on this area sufficiently cover many other groups' significant contributions to STS inhibitor chemistry and biology [6][7][8][9]. Synthesis pathways for steroids with oestrogenic and androgenic properties.…”
Section: Introductionmentioning
confidence: 99%
“…Significant advances have been made in the design of inhibitors targeting steroid sulfatases involved in hormone dependent cancers and some are in Phase II clinical trials [37]. There are, however, currently no targeted, effective inhibitors of carbohydrate sulfatases despite their emergence as novel targets for disease intervention [25,38,39].…”
Section: Enzyme Inhibition Studies Using Ce-based Desulfation Detectimentioning
confidence: 99%